What are the Challenges Faced by the FDA in Regulating Nanotechnology?
Regulating nanotechnology presents several challenges:
Limited understanding of the long-term effects of nanomaterials on human health and the environment. Difficulty in standardizing methods for characterizing nanomaterials due to their diverse properties. Need for interdisciplinary expertise to evaluate the complex interactions of nanomaterials. Rapid pace of innovation in nanotechnology, which can outstrip regulatory frameworks.
